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ABSTRACT
INTRODUCTION: There is ample current research on new methods of treatment for spinal cord infarc-
tion. In this respect, in recent years, recombinant erythropoietin (REP) has been gaining increasing interest 
among medical professionals; REP is a drug with proven protective activity in response to ischemia of dif-
ferent organs and tissues including the brain and the spinal cord.
We aim to study the dynamics of morphological changes in spinal cord ischemic lesions in rats influenced 
by REP.
MATERIALS AND METHODS: The study was conducted on 40 mature rats. The animals were divided 
into two series of experiments, 20 animals each. The first series of animals was the group compared to the 
spinal cord ischemia model. In the second series 1000 international units (0.0084 mg) of REP in 3, 24, and 
48 hours were administered intraperitoneally to the animals. After the animals had been sacrificed, the spi-
nal cord was removed for further histologic and morphometric study. The obtained results were processed 
using analysis of variance. The statistical significance of differences between the compared parameters of 
the groups was assessed with the Mann-Whitney U test.
RESULTS: The study of the spinal cord specimen showed that REP administration results in significant-
ly higher levels of normal neurons and blood vessels, and in significantly lower count of chromatolytic neu-
rons and ghost cells at all stages of the experiment.
CONCLUSION: At the early stages of the experiment, the REP effect increases the ischemic tolerance of 
neurons and enhances the proliferation rate of gliocytes and endotheliocytes with the development of a new 
blood stream.
Keywords: spinal cord, experimental ischemia, pathomorphological and functional disorders, recombi-
nant erythropoietin
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INTRODUCTION
The incidence of spinal cord vascular diseases 
is much higher than it was believed. According to re-
cent statistics, the ratio of cerebrovascular diseases to 
spinal cord vascular diseases is 4:1.
Spinal cord infarction is a circulatory distur-
bance of the spinal cord that causes a spinal cord in-
jury and dysfunction due to insufficient or blocked 
blood supply. 
The damaging effect of ischemia results in irre-
versible neuronal changes – the formation of focal ne-
crosis and infarct core (1). For several hours the area 
of the central “punctate” infarction is surrounded by 
ischemic, but viable tissue – the so-called ischemic 
penumbra (2). In the area of the penumbra, the en-
ergy metabolism is mostly preserved, and the chang-
es are functional, not structural (3). It is the region of 
“critical” or “misery” perfusion where the neuronal 
function is reduced because the tissue metabolic de-
mands are not met, but the cells are viable, and their 
ionic homeostasis is preserved. Early and appropriate 
drug delivery to the area of penumbra prevents neu-
ronal cytolysis.
For this reason, there is ample current research 
on new methods of treatment for spinal cord infarc-
tion. In this respect, in recent years recombinant 
erythropoietin (REP) has been gaining increasing 
interest among medical professionals; REP is a drug 
with proven protective activity in response to isch-
emia of different organs and tissues including the 
brain (4) and the spinal cord (5). It has been estab-
lished that REP has anti-apoptotic and anti-hypoxic 
effect, stimulates angiogenesis and neurogenesis (4, 
6–8), and the pleiotropic action of REP is associated 
with specific receptors at the surface of different cells 
including neurons (9).  
MATERIALS AND METHODS
We conducted our study on 40 mature outbred 
rats of both sexes, 200-250 g of weight. All animals 
were divided into 2 series of experiments. 
1st Series of Experiments
Using the technique suggested by Sufianova et 
al. (10) we modeled spinal cord ischemia in 20 ani-
mals (control group). Transient ischemia of the lum-
bar spinal cord was induced with total intravascu-
lar occlusion of the abdominal aorta and its branch-
es.  For this purpose, occluders (sterilized 3-0 chro-
mic catgut) were inserted into both femoral arteries 
towards the heart; insertion depth was determined 
based on the distance between the xiphoid process 
and the tail set. After that, 0.3 ml of 3% feracrylum 
solution was introduced into left common carotid ar-
tery, below the site of ligation, towards the occlud-
ers. 45 minutes later the occluders were removed, and 
the femoral arteries were clipped. The animals were 
sacrificed on days 3, 7, 14, and 30 after the ischemia 
modeling. We have examined 5 rats at each stage of 
observation.
2nd Series of Experiments
In 20 animals we modeled spinal cord ischemia 
using the technique described above (2nd series of ex-
periments). Three hours after the operation, 1000 in-
ternational units (IU) (0.0084 mg) of recombinant 
erythropoietin («EPOKRIN 2000 ME») at the rate of 
5000 IU (0.0420 mg) per kg of bodyweight was ad-
ministered intraperitoneally to each animal. 24 and 
48 hours after creation of ischemia the drug admin-
istration was repeated in a dose of 1000 IU (0.0084 
mg). The animals were sacrificed on days 3, 7, 14, and 
30 after the ischemia modeling. We have examined 5 
rats at each stage of observation. 
After the animals were sacrificed, we prepared 
histological sections of the spinal cord and stained 
them with hematoxylin and eosin for microscopic 
investigation; the Bielschowsky technique was used 
for visualization of the myelinated fibers, and the 
Nissl staining was used for analysis of the Nissl sub-
stance. Microsections were investigated with a Leica 
DMRXA microscope (Germany).  
For the objective assessment of the parameters 
of morphological changes we considered the follow-
ing values: 1) count of intact (normal) neurons per 
unit area; 2) count of chromatolytic neurons per unit 
area; 3) count of ghost cells per unit area; 4) number 
of small blood vessels (capillaries and arterioles) per 
unit area.
Morphometric studies were conducted using 
DiaMorf Cito-W color image analysis software (Rus-
sia) at microscope magnification x 400, in 10 random 
fields of view.
The obtained results were processed by IBM PC 
using Statistica 6.0 software suite (StatSoftIns, USA). 
Methods from variation statistics were used. The sta-
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tistical significance of the differences in the com-
pared parameters in the groups was evaluated with 
the Mann-Whitney U test. The differences were con-
sidered significant at P<0.05 which corresponds to 
95% confidence interval.
RESULTS AND DISCUSSION
Histologic study of lumbar enlargement spec-
imens from the first series of experiments revealed 
the most prominent changes in the ventral horns – 
chromatolysis of cytoplasm, nuclear pyknosis, and 
dissolution of the basophilic substance in neurons so 
that they turned into ghost cells. Intact and hyper-
chromic neurons were also seen. Neuronophagia was 
revealed, as well as pericellular and perivascular ede-
ma in the white matter. On day 7, in the central area 
of ischemic focus, destructive changes in the neurons 
were observed, and intact neurons were also seen in 
the perifocal area. The number of hypertrophic as-
trocytes was increased, activation of microglia was 
observed, and macrophages were seen. By days 14 
and 30, the morphological changes in the spinal cord 
tissues were similar to those on day 7. At the same 
time, in the ischemic area a glial-connective tissue ci-
catrix was formed. 
According to the results of the quantitative 
study of spinal cord specimens of the first series of 
experiments, the count of normal neurons (24.3±1.1) 
was significantly lower only on day 7, and the count 
of chromatolytic neurons was notably growing from 
day 7 (36.4±0.9) till the end of experiment. In turn, 
the count of ghost cells was also growing, but the sig-
nificant increase was only on day 7 (58.1±2.5), and 
the number of blood vessels significantly increased 
on day 30 (10.2±0.6) of observation (Table 1). 
The study of spinal cord specimens of the sec-
ond series of experiments on days 3 and 7, and at fur-
ther stages of observation (days 14 and 30) revealed 
that neurons were mostly preserved, though there 
were occasional hyperchromic cells, but only a few 
cells had signs of swelling or shrinkage. Capillaries 
and arterioles were hyperemic, and their endothelial 
cells had a high proliferation rate. At all stages of the 
experiment there were no glial-connective tissue ci-
catrices which indicated the low expression of isch-
emic injury, without formed necrotic zone in the spi-
nal cord tissues.
The morphometric analysis of spinal cord 
specimens from the second series of experiments 
showed that the count of normal neurons in com-
parison with the pervious stage of experiment in-
creased insignificantly, except on day 7 (81.8±2.8), 
and the count of chromatolytic neurons significant-
ly decreased on day 7 (20.1±0.8), day 14 (17.1±0.5) 
and day 30 (12.2±0.3). At the same time, the count 
of ghost cells was significantly decreasing: 10.1±0.2 
(day 7); 8.3±0.4 (day 14); 3.8±0.5 (day 30). The num-
ber of small blood vessels was significantly higher on 
day 7 (11.9±0.2) and day 30 (17.3 ± 0.3). Besides, the 
count of normal neurons and the number of small 
Examined param-
eter (per unit area)
Series of  
experiment
Stage of observation (days)
3 7 14 30















































Note: the 1st series of experiments – spinal cord ischemia model (control group); 2nd series of experiments – spinal cord ischemia 
model treated with REP; *– p<0.05 in comparison with the previous stage of observation for each series of experiments; **– p<0.05 in 
comparison with the 1st series of experiments.
Table 1. Dynamics of quantitative changes in the examined parameters of ischemic spinal cord tissues in rats from the 
different series of experiments (М±m)
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blood vessels was significantly higher, and the count 
of chromatolytic neurons and ghost cells was signif-
icantly lower at all stages of observation in compari-
son with the 1st series of experiments (Table 1).
 CONCLUSION
Thus, in all animals with spinal cord ischemia 
treated with recombinant erythropoietin the histo-
logic study of spinal cord specimens on days 3 and 
7 of experiment, as well as at further stages of ob-
servation (days 14 and 30), revealed that neurons 
were mostly preserved, though there were occasion-
al hyperchromic cells, but only few cells had signs of 
swelling or shrinkage. At the same time, the count of 
ghost cells was decreasing – and significantly on day 
7 – in comparison with day 3. The number of blood 
vessels significantly increased on days 7 and 14 of the 
experiment. Besides, the count of chromatolytic neu-
rons and ghost cells was lower at all stages of experi-
ment in comparison with the animals from the con-
trol group.
The study of the model of rat lumbar spinal 
cord ischemia induced with total intravascular oc-
clusion of the abdominal aorta and its branches re-
vealed neuroprotective and angiogenic effect of re-
combinant erythropoietin expressed in the signifi-
cant increase of neuronal resistance to injury and in 
the increased number of small blood vessels in the 
ischemic area.
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